Promotions & Moves

BioDelivery Sciences Appoints Interim CEO

Jeffrey Bailey has led both public and private healthcare companies leveraging his leadership experience in commercial, supply chain and business development

By: Contract Pharma

Contract Pharma Staff

BioDelivery Sciences International, a specialty pharmaceutical company dedicated to serious and complex chronic conditions, has appointed Jeffrey A. Bailey, as interim Chief Executive Officer and a member of the Company’s Board of Directors. Mr. Bailey succeeds Herm Cukier as CEO. Mr. Bailey has led both public and private healthcare companies where he has leveraged his leadership experiences in commercial, supply chain and business development, as well as in-licensing and transactions. His e...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters